"Over the last two years, Acrux has generated $20 million in revenue. The majority of this is revenue from our commercialised products."
Are these guys taking the piss, or am I missing something?
In both financial years ending June 2023 and June 2024 the business generated a sum total licencee fee 'revenue' of about $17.4m (ie operating revenue, ex of royalty divestments etc). But of this $14.7m were "pass though" expenses for cost-of-goods to the commercial partner (ie re-imbursement to Acrux of costs). No reasonable person would class this as "revenue".
So in my book, that leaves revenue from commercialised product, in the two years, of about $2.7m. If we include the tax-payer funded generosity a la tax rebates, we can throw in an extra $6.3m, for a sum total of $8.9m. So of revenues that could be classed as "normal operating", about 70% are tax rebates.
Hello? Can someone please tell me I'm getting something wrong!
- Forums
- ASX - By Stock
- ACR
- Ann: AGM Presentation
ACR
acrux limited
Add to My Watchlist
0.00%
!
2.0¢

Ann: AGM Presentation, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.155M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 2.0¢ | $12.32K | 616.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 425000 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 276349 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 425000 | 0.019 |
2 | 187800 | 0.018 |
2 | 469000 | 0.017 |
1 | 66732 | 0.015 |
1 | 70000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 276349 | 1 |
0.021 | 403150 | 1 |
0.022 | 204574 | 4 |
0.023 | 125126 | 5 |
0.024 | 306848 | 8 |
Last trade - 10.02am 18/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online